Bioceres Crop Solutions Financials - Benzinga

Bioceres Crop Solutions Corp

BIOXNASDAQ

Trade with Public

Trade with Public

$0.3455

-0.0125-3.49%

À la clôture: Sep 29, 5:00 PM EST

$0.3340

-0.0115-3.33%

Après les heures: 4:03 PM EST

Aperçu Actualités Prévisions de résultats Objectifs de coursDonnées financièresSentiment Comparer Options Rapport sur les stocks

Bioceres Crop Solutions Financials

Bioceres Crop Solutions (BIOX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Reported Earlier, Bioceres Crop Solutions Q4 EPS $(0.50) Misses $(0.06) Estimate, Sales $55.900M Miss $79.000M Estimate

Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.06) by 733.33 percent. This is a 34.21 percent increase over losses of $(0.76) per

Benzinga Newsdesk

PRO
Bioceres Crop Solutions Q3 EPS $(0.16) Misses $(0.05) Estimate, Sales $39.400M Miss $54.500M Estimate

Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.05) by 220 percent. This is a 300 percent decrease over losses of $(0.04) per share

Benzinga Newsdesk

PRO
Bioceres Crop Solutions Q1 EPS $(0.12) Misses $(0.07) Estimate, Sales $77.300M Miss $90.225M Estimate

Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.07) by 66.67 percent. This is a 50 percent decrease over losses of $(0.08) per share

Benzinga Newsdesk

PRO
Bioceres Crop Solutions Q4 EPS $(0.76) Misses $0.10 Estimate, Sales $74.70M Miss $110.19M Estimate

Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $0.10 by 859 percent. This is a 2430 percent decrease over losses of $(0.03) per share

Benzinga Newsdesk

Earnings Scheduled For September 9, 2025

Benzinga Insights

A Preview Of Bioceres Crop Solutions's Earnings

Benzinga Insights

© 2026 Benzinga | All Rights Reserved